Australia’s first large-scale mRNA manufacturing facility is set to deliver significant economic and health benefits, with new modelling showing it could add $220 million to the economy each year, support nearly 1,000 ongoing jobs, and provide pandemic preparedness benefits valued at up to $4.8 billion over the next three decades. …
Australia’s first mRNA facility promises jobs, growth and health security
September 23, 2025 Latest NewsBioPharmaNews of the Day
Latest Video
Georgia Forrest
New Stories
-
There is no negotiation, yet, so be careful not to give the impression of conceding anything
February 11, 2026 - - Latest News -
Arrotex and Pfizer forge strategic pharmacy partnership for ENBREL in Australia
February 11, 2026 - - Latest News -
Amplia expands U.S. footprint as AMPLICITY pancreatic cancer trial gains momentum
February 11, 2026 - - Australian Biotech -
Canine osteoarthritis study offers compelling translational evidence for PPS
February 11, 2026 - - Australian Biotech -
CSL presses ahead with transformation as earnings slip and leadership changes
February 11, 2026 - - Latest News -
This might be the real once-in-a-generation opportunity achieve reform
February 11, 2026 - - Latest News -
CSL confirms leadership transition as Gordon Naylor steps in as interim CEO
February 10, 2026 - - Latest News